The Lyme disease diagnostic market is expanding as rising disease awareness, increasing case detection, and advances in diagnostic technology increase demand for accurate and timely testing. The market was valued at USD 800 million in 2024 and is projected to reach USD 1.5 billion by 2035, at a CAGR of 5.9%.wiseguyreports

Serologic testing remains an important diagnostic category, while PCR and other molecular approaches are gaining attention for their ability to support earlier and more sensitive pathogen detection. Enzyme-linked immunosorbent assay and Western blot testing continue to play key roles in screening and confirmatory workflows.

Hospitals, diagnostic laboratories, and research institutions are major end users. Diagnostic laboratories are especially important because they support high-volume testing, faster reporting, and access to specialized methodologies. The growing use of digital systems and telehealth may also help improve diagnostic access for patients in remote locations.

North America leads the market due to high disease prevalence, improved awareness, and advanced diagnostic infrastructure. Europe is also expanding through disease-surveillance programs and increased recognition of tick-borne conditions. Asia-Pacific represents a developing opportunity as healthcare investment and diagnostic capacity grow.

Key companies active in the market include DiaSorin, Quest Diagnostics, Roche, bioMérieux, Hologic, Siemens Healthineers, Abbott, Thermo Fisher Scientific, Becton Dickinson, and Ortho Clinical Diagnostics. Their strategies focus on more sensitive tests, laboratory partnerships, and broader access to molecular diagnostics.wiseguyreports

Read more: Lyme Disease Diagnostic Market

People Also Ask

Q1. What tests are used to diagnose Lyme disease?
Common methods include serologic tests, ELISA, Western blot testing, and PCR-based molecular tests.

Q2. Why is rapid Lyme disease testing important?
Earlier and more reliable testing can support timely clinical evaluation and treatment decisions.

Tags: Lyme disease diagnostics, PCR testing, serologic testing, ELISA, molecular diagnostics, tick-borne disease